• Home
  • Supplier
  • Distributor
  • Career
  • Contact
  • CSR
NSE Logo
Infinium Pharmachem Limited Logo
  • About Us
    • Overview
    • Board of Directors
    • Vision & Mission
    • Our Commitment
    • Milestones
    • Corporate Management
    • Manufacturing Facility
    • Reserach & Development Facility
    • Our Customers
    • Infinium Advantages
  • Products
    • A To Z Products
    • Iodine Derivatives
    • APIs
  • Industries
    • Overview
    • Pharmaceuticals & Biotech
    • Specialty & Performance Chemicals
    • Dairy, Food & Neutraceutical
    • Animal Care
    • Agrochemical
    • Paints, Coating, Dyes & Textile
    • Ink, Paper & Printing
    • Rubber & Nylon Tyre
    • Oil & Gas
    • Cosmetics, Sanitation, Personal Care & Industrial Care
    • Gold & Imitation Jewelry
    • Medical
    • Radiography
    • Nuclear Science
    • Gemological
    • Renewable Energy (Solar,Biomass)
    • Electrical
    • Electronics
    • Mechanical
    • Aquarium
    • Photography
    • Tobacco
    • Fireworks
  • CRAMS
  • Quality
    • Overview
    • Good Manufacturing Practices (GMP)
    • Quality Services
    • Certifications
    • GHS
    • Labeling & SDS
    • Packaging
  • Support
    • Logistics
  • Investors
    • Shareholder’s Information
      • Shareholding Pattern
      • Intimation to Stock Exchanges
    • Financial Information
      • Half Yearly Financial Results
      • Audited Financial Result
      • Annual Report
      • Notice of 21’st AGM
      • Notice of 19’th AGM
      • Investor Contact
    • Corporate Governance
      • Board of Directors
      • Composition of the Committees
    • Material Creditors
      • List Of Material Creditors
    • IPO
      • DRHP
      • Addendum
      • Disclosure of Material Contracts and Documents
      • Prospectus
    • Subsidiary Company Financials
      • Shanghai Tajilin Industrial Co. Ltd.
      • Infinium Green Energy Pvt. Ltd.
    • Investor Update
      • Financial Year 2024
  • EHS
  • NEWS & EVENTS
    • News
    • Events

Investors

  • Home
  • Investors

Half Yearly Financial Results

  • HY1 FY22-23
  • FY22-23

Unaudited Financial Results with limited review report for Half Year ended on 30th September, 2023

Unaudited Financial Results with limited review report for Half Year ended on 30th September, 2024

Unaudited Standalone Financial Results for the Half Year ended on 30th September, 2025

Unaudited Consolidated Financial Results for the Half Year ended on 30th September, 2025

Investors Presentation On Unaudited Consolidated Financial Results for the Half Year ended on 30th September, 2025

Latest Annual Reports

View earlier reports
Overview Image

Annual Report 2022-23

Overview Image

Annual Report 2021-22

Overview Image

Annual Report 2020-21

Overview Image

Annual Report 2019-20

Overview Image

Annual Report 2023-24

Overview Image

Annual Report 2024-25

Corporate Office

  • INFINIUM PHARMACHEM LIMITED
    Suite #205, "SIGMA PRIME", Second Floor,
    Nr. Sardar Patel Statue, V.U. Nagar GIDC Road,
    Vallabh Vidyanagar - 388120 Gujarat, INDIA.

Contact Us

  • +91-2692-238849 / 238850
  • info@infiniumpharmachem.com
  • export@infiniumpharmachem.com

Downloads

Corporate Presentation Corporate Brochure
Copyright © 2026 Infinium Pharmachem Limited - All Rights Reserved
Designed by GID and Promoted by MID